Pinnacle Clinical Research reposted this
Family Physician and Obesity Medicine / Medical Director / PI / Working on MPH / Mental health advocator/ Author
Great to be part of an groundbreaking study. Will continue to break barriers in MASH treatments. Rashmee Patil Graciela Marje Alyssa Gutierrez Janie Avila Pinnacle Clinical Research Summit Clinical Research
Incretins are REVOLUTIONIZING the care of People with #MASH and #Pemvidutide offers "liver-directed therapy" (LDT) with the combination of GLP-1/Glucagon. Glucagon stands out since it is the only Incretin to have receptors in the liver (thus LDT) 🎯. New data on pemvidutide also shows that it preserves lean body mass, which is critical for People with MASH who may also suffer from sarcopenia. It was an honor and a great experience to collaborate on this recently published study with Dr. Stephen Harrison and the Altimmune, Inc. team highlighting the potency of PEMVI on Steatotic Liver Disease. This can be downloaded here. https://lnkd.in/gt6-zHHQ in Journal of Hepatology. A phase 2b study for PEMVI in MASH is ongoing and being supported by many key investigators including Mazen Noureddin, MD, MHSc, Naim Alkhouri, MD, FAASLD, Edward Mena, Anita Kohli, Paul Kwo, Angie Coste, Dimple Desai, MD, FAAFP, DABOM, Edgardo Rivera-Rivera, Craig McClain, Muhammad Sheikh. MD, FACP, FACG, AGAF, and Victor Araya plus many others 😎 . #AASLD, #EASL Global Liver Institute